CCP
EDIT icon

Clough Capital Partners’s Editas Medicine EDIT Stock Holding History

Clough Capital Partners’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-392,087
Closed -$8.75M – 141
2017
Q1 		$8.75M Buy
392,087
+341,687
+678% +$7.08M 0.56% 56
2016
Q4 		$818K Buy
+50,400
New +$765K 0.05% 125

Other funds holding EDIT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
PVMCV
Polaris Venture Management Co VI Boston, Massachusetts $43.1M AUM 78.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Clough Capital Partners's EDIT Position: Q2 2017 in Review

Clough Capital Partners sold out of Editas Medicine (EDIT) in Q2 2017, closing a stake of 392,087 shares — an estimated $8.75M sold.

Clough Capital Partners first reported a position in EDIT in Q4 2016 and held it in 2 quarters. The position peaked at $8.75M in Q1 2017. 110 funds tracked by Wall St. Rank hold EDIT as of Q2 2017.

  • Clough Capital Partners reported no remaining Editas Medicine position as of Q2 2017 after selling out during the quarter.
  • Clough Capital Partners sold 392,087 Editas Medicine shares in Q2 2017, an estimated $8.75M.
  • Clough Capital Partners first reported a position in Editas Medicine in Q4 2016 and held it in 2 quarters.
  • Clough Capital Partners's Editas Medicine position peaked at $8.75M in Q1 2017.
  • 110 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2017.

Based on Clough Capital Partners's 13F filing for Q2 2017, filed 14 Aug 2017.